Continuous Glucose Monitoring Market Set to Double, Surpassing USD 12.6 Billion by 2035

The Continuous Glucose Monitoring (CGM) market is poised for strong growth as demand for real-time diabetes management solutions accelerates worldwide. Valued at USD 5.8 billion in 2024, the industry is projected to surpass USD 12.6 billion by 2035, reflecting a healthy CAGR of 7.4% from 2025 to 2035. This expansion is driven by rising diabetes prevalence, increasing adoption of minimally invasive monitoring technologies, and growing preference for continuous over traditional glucose testing methods among both patients and healthcare providers.

Continuous Glucose Monitoring (CGM) Market is expanding at a very high rate with the fast-rising prevalence of diabetes and demand for efficient management systems. CGM systems provide accurate, real-time information on blood glucose level so that the patient can take proper action on diet, exercise, and insulin therapy. This not only enhances glycemic control but also reduces the risk of complications of diabetes, hence making it a useful tool for both patients and medical practitioners.

Dive Deeper into Data: Get Your In-Depth Sample Now! https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1169

🗺️ Regional Analysis: Growth Engines of the CGM Market

The global market growth is highly concentrated in a few key geographies:

North America: Expected to dominate the market share (around 39% - 43.5% by 2035). This dominance is fueled by a high incidence of diabetes and obesity, well-established healthcare infrastructure, robust reimbursement policies, and the early adoption of advanced digital health solutions

Asia-Pacific (APAC): Projected to be the fastest-growing region. The rapid growth is driven by the huge and rising diabetic population in countries like China and India, improving healthcare infrastructure, and government initiatives promoting digital health and diabetes awareness.

Europe: Significant growth is supported by robust healthcare systems and increasing patient and physician awareness, with countries like Germany and the UK leading adoption.

🔍 Market Segmentation (Illustrative)

While specific segmentation data can vary, the key components, end-users, and applications driving the market include:

Segmentation Category

Key Segments and Insights (2025-2035)

By Component/Product Type

Sensors are expected to hold the largest market share (44.7% - 84.89% by 2035) and fastest growth due to their disposable nature and continuous demand for replacement. Other segments include Transmitters and Receivers.

By End-User/Setting

Home Care Settings are anticipated to dominate (around 50.1% - 74.27% share by 2035), driven by rising health consciousness, demand for self-monitoring, and the growth of remote patient monitoring/hospital-at-home initiatives. Other segments include Hospitals, Specialty Diabetes Clinics, and Diagnostic Centers.

By Application

Diabetes Management remains the primary application, but new, high-growth segments include Sports Nutrition and general Wellness/Preventive Care for non-diabetic populations (e.g., pre-diabetes, metabolic health).

By Technology/Service Type

This includes electrochemical (current standard) and emerging technologies like Non-Invasive Sensing (e.g., optical/spectroscopy) and Implantable Systems.

By Sourcing Type/Channel

This primarily includes sales through Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies, with a growing direct-to-consumer model for wellness CGMs.

📈 Market Drivers and Challenges

Market Drivers

Rising Global Diabetes Prevalence: The primary driver is the staggering increase in Type 1 and Type 2 diabetes cases worldwide, creating an essential need for effective management tools.

Technological Advancements: Innovations such as smaller, more accurate, and longer-lasting sensors (14+ days), integration with Automated Insulin Delivery (AID) systems, and development of non-invasive monitoring are enhancing user appeal and clinical utility.

Shift to Remote Patient Monitoring (RPM) and Digital Health: CGM devices seamlessly integrate with telehealth platforms, mobile apps, and AI-driven analytics, enabling clinicians to monitor patients remotely and provide personalized, timely interventions.

Expanded Use Cases (Beyond Insulin Users): The market is expanding into pre-diabetes, non-insulin-using Type 2 diabetes, and the broader consumer health/fitness and sports nutrition segments for metabolic health tracking.

Favorable Reimbursement: Expanding insurance coverage (e.g., Medicare in the US) for a wider range of diabetes patients is lowering financial barriers to adoption.

Market Challenges

High Cost and Affordability: The high initial device cost and ongoing expenses for disposable sensors limit access, particularly in low-income and uninsured populations, as well as in emerging markets.

Regulatory Complexity: Navigating regional regulatory requirements for new devices (especially non-invasive technology) and ensuring compliance can be challenging for manufacturers.

Data Overload and User Compliance: The constant data flow from CGM devices can lead to data overload or alarm fatigue, potentially causing user burnout or non-adherence.

Accuracy and Inaccuracy Concerns: While greatly improved, sensor inaccuracy in certain conditions (e.g., rapid glucose changes) remains a concern that can impact user trust and clinical decisions.

Cyber-Security and Data Privacy: As devices become more connected, securing patient data and ensuring privacy is a growing challenge.

💡 Market Trends and Future Outlook

Non-Invasive CGM: The "holy grail" of glucose monitoring, non-invasive technology (e.g., using Near-Infrared Spectroscopy, tear, or sweat analysis) embedded in smartwatches or wristbands, is a key focus of R&D and could fundamentally disrupt the market.

AI and Predictive Analytics: Advanced algorithms and AI are being integrated into CGM systems to provide predictive alerts (e.g., forecasting hypoglycemia), personalized treatment recommendations, and enhanced data interpretation for both patients and healthcare providers.

Over-the-Counter (OTC) CGM: The launch of OTC CGMs, like Dexcom's Stelo and Abbott's Lingo/Libre Rio, is a major trend to capture the non-insulin-using Type 2 and general wellness markets, significantly broadening market penetration.

Increased Integration: Further seamless integration of CGM data with insulin pumps (creating "closed-loop" or AID systems), smart pens, and Electronic Health Records (EHRs) will be standard.

Long-Term and Implantable Sensors: The development of implantable sensors that last up to 365 days (like Eversense) and longer-wear disposable sensors is addressing the need for improved convenience and lower lifetime ownership costs.

Buy this Premium Research Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=1169<ype=S

🔬 Key Market Study Points

For companies looking to succeed in the CGM market, the following points are critical:

Prioritize User Experience (UX): Devices must be smaller, easier to insert, comfortable, and simple to integrate with existing smart devices to drive compliance and adoption.

Focus on Affordability and Accessibility: Developing cost-effective sensor technologies and leveraging subscription-based models are crucial to penetrating emerging economies and the broader Type 2 diabetes market.
Invest in Non-Invasive R&D: Companies making validated breakthroughs in non-invasive technology will capture significant market share.

Strategic Partnerships: Collaborations between CGM manufacturers, digital health platforms, and insulin delivery system providers are essential for building integrated, holistic diabetes care solutions.

⚔️ Competitive Landscape and Recent Developments

The CGM market is highly competitive, dominated by a few major players alongside innovative startups.24

Key Market Player

Recent Developments & Strategy (2024-2025)

Abbott Laboratories

Strong market leader with the FreeStyle Libre portfolio (Intermittently Scanned CGM). Key focus on OTC expansion (Lingo, Libre Rio) and maintaining an affordability edge. Received FDA clearance for new OTC systems.

DexCom, Inc.

Dominates the Real-Time CGM segment with Dexcom G6/G7 systems. Launched Dexcom ONE+ in new European markets (Feb 2025). Focus on predictive alerts and integration with AID systems. Launched OTC device Stelo (Aug 2024).

Medtronic plc

Offers the MiniMed 780G system with the Simplera Sync sensor. Received CE Mark approval for MiniMed 780G system with Simplera Sync, featuring a smaller sensor size and simplified insertion process (Jan 2024).

Senseonics Holdings, Inc. / Ascensia Diabetes Care

Offers the Eversense implantable CGM system, receiving an iCGM designation from the FDA.

Other Recent Developments:

Integration of AI: Roche's AI-powered glucose monitoring system received CE marking (July 2024) to predict nocturnal hypoglycemia.
Local Market Innovation: Indian brands like DrStore launched India's first Bluetooth-enabled CGM (Tracky, June 2025), focusing on affordability and local needs.
Wellness Market Funding: Hello Inside acquired funding (Sept 2024) to focus on metabolic health for women through CGM data.
Explore Latest Research Reports by Transparency Market Research:

Sterile Gauze Dressing Market - https://www.transparencymarketresearch.com/sterile-gauze-dressing-market.html

Medical Microbiology Testing Technology Market - https://www.transparencymarketresearch.com/microbiology-testing-technologies-market.html

Spectrometry Market - https://www.transparencymarketresearch.com/spectrometry-market.html

Mass Spectrometer Market - https://www.transparencymarketresearch.com/mass-spectrometer-market.html

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com

This release was published on openPR.